Find out which stocks performed best in yesterday's range-bound market

Markets were flat yesterday, yet Bright Mountain Media, Inc., UroGen Pharma Ltd., Iovance Biotherapeutics, Inc. showed impressive gains and made this list of top gainers.

Markets did not have a clear cut direction — after dropping 0.14%, Dow Jones closed at 34,052. Nasdaq closed 12,200 after a stable day.

This limbo state is reflected by published market data as United States ISM Manufacturing PMI (Apr) released yesterday at 14:00 UTC with a figure of 47.1, while the previous figure was 46.3.

Despite yesterday's flat session, several stocks are managing to post notable gains. Take a look at the market's Top Gainers:

+8.91%: Norwegian Cruise Line gains 8.91% within $13.12 to $14.65 daily range

The US cruise line rose as high as $14.65 before giving up its gains and dropping back to $14.54 before the close on yesterday. Currently, the world's 3rd largest cruise line has a market capitalization of $6.13 billion with an average daily trading volume of 12.58 million shares. So far this year, it has been beating the Nasdaq by 10.19%.

+14%: Iovance Biotherapeutics posts solid session with 14% gain; upside capped at $6.54

Iovance Biotherapeutics rallied 14% and ended the session at $6.43. The company is currently trading with a market cap of $1.43 billion with an average daily trading volume of 3.41 million shares.

Iovance Biotherapeutics is trading in a $5.59 – $6.54 range prior to its earnings announcement.

+29.41%: Bright Mountain Media opened at 5.5 cents yesterday before posting solid session gaining 29.41%

Bright Mountain Media surges 29.41% to close at 5.5 cents yesterday. The company has a market cap of $8.23 million with an average daily trading volume of 11,910 shares.

UroGen Pharma | Closed +23.3% at $14.29

Having soared to a high of $14.29 approximately a day ago, the biotechnology company is now trading 18.89% lower. UroGen Pharma's market cap currently stands at $334.96 million with an average daily volume of 261,514 shares.

UroGen Pharma is trading in a $11.26 – $16.11 range prior to its earnings announcement.